Clinical trials in Varberg

9 clinical trials in Varberg, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SwedenKliniska-Provningar.se

Varberg at a glance

clinical trials

Paediatric trials0
Research sites1

Quick filters

9 trials in Varberg

Open in trial search

Therapy cessation

Recruiting

Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

Registered drugNo placebo

Study of the effects of stopping elranatamab and teclistamab treatment in patients with multiple myeloma who have had a significant response to therapy.

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Elranatamab
Sponsor:Vaestra Goetalandsregionen

Contact Research Centre

Induced labour+1

Recruiting

Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

Registered drugNo placebo

Study on Misoprostol for Inducing Labor in Pregnant Women: Comparing Outpatient and Inpatient Settings

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:Misoprostol
Sponsor:University Of Gothenburg

Contact Research Centre

Atrial fibrillation+2

Recruiting

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo

Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Apixaban
Sponsor:Karolinska University Hospital

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not yet recruiting

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo

Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

Registered drugNo placebo

Sweden

Participants:65+ years
Substances:Cyclophosphamide
Sponsor:Region Skane

Contact Research Centre

Chronic kidney disease+1

Not recruiting

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug

Sweden

Participants:18–64 years · 65+ years
Substances:Baxdrostat
Sponsor:AstraZeneca AB

Contact Research Centre

Heart failure with preserved ejection fraction

Not recruiting

Study of spironolactone and eplerenone in patients with heart failure with preserved ejection fraction (HFpEF)

Registered drugNo placebo

Study of spironolactone and eplerenone in patients with heart failure with preserved ejection fraction (HFpEF)

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Altizide
Sponsor:Region Uppsala

Contact Research Centre

Chronic lymphocytic leukaemia

Not recruiting

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Ibrutinib
Sponsor:University Of Cologne

Contact Research Centre

Plasma cell myeloma

Not recruiting

Study on the Effectiveness of Ixazomib, Lenalidomide, and Dexamethasone in Treating Newly Diagnosed Multiple Myeloma in Patients Eligible for Transplant

Registered drugNo placebo

Study on the Effectiveness of Ixazomib, Lenalidomide, and Dexamethasone in Treating Newly Diagnosed Multiple Myeloma in Patients Eligible for Transplant

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Ixazomib
Sponsor:HUS-Yhtymae

Contact Research Centre

Type 1 diabetes mellitus

Not recruiting

Study on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients

Registered drug

Study on Ixekizumab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients

Registered drug

Sweden

Participants:18–64 years
Substances:Ixekizumab
Sponsor:NU Hospital Group-Vaestra Goetalandsregionen

Contact Research Centre

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Varberg

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking research focusing on chronic lymphocytic leukemia and blood cancers, evaluating novel therapeutic combinations for optimal patient outcomes.

Treatment-naive CLL therapy evaluation
Multiple myeloma interventions
Diffuse Large B-Cell Lymphoma treatment

Advanced studies comparing various treatment combinations to enhance therapeutic efficacy in blood disorders.

02 Cardiovascular & Renal Medicine

Innovative trials examining treatments for chronic kidney disease and heart conditions, with special attention to complex comorbidities.

CKD with hypertension management
Heart failure with preserved ejection fraction
Atrial fibrillation in kidney disease

Comprehensive research exploring new therapeutic approaches for cardiovascular and renal conditions.

03 Endocrinology & Maternal Health

Clinical investigations in diabetes management and maternal healthcare, focusing on innovative treatment approaches.

Type 1 diabetes interventions
Labor induction optimization
Insulin secretion studies

Patient-centered research aimed at improving treatment outcomes and healthcare delivery methods.

Back to Sweden All countries